Vlado Perkovic Selected Research

Kidney Diseases (Kidney Disease)

2/2024	Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data.
12/2023	Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression.
9/2023	Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.
1/2023	Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.
1/2023	Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
12/2022	Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice.
7/2022	Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria.
1/2022	Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
1/2022	The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial.
12/2021	Availability, coverage, and scope of health information systems for kidney care across world countries and regions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vlado Perkovic Research Topics

Disease

138	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2006
84	Chronic Renal Insufficiency 04/2024 - 10/2007
59	Albuminuria 01/2024 - 08/2009
44	Heart Failure 04/2024 - 12/2009
42	Kidney Diseases (Kidney Disease) 02/2024 - 06/2012
42	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 08/2009
40	Renal Insufficiency (Renal Failure) 02/2024 - 01/2003
33	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2009
30	Stroke (Strokes) 04/2024 - 10/2007
27	Myocardial Infarction 04/2024 - 03/2012
27	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2011
23	Vascular Diseases (Vascular Disease) 11/2019 - 08/2006
20	Proteinuria 12/2023 - 03/2008
20	Body Weight (Weight, Body) 12/2023 - 08/2013
14	Infections 01/2022 - 08/2013
11	IGA Glomerulonephritis (IGA Nephropathy) 12/2023 - 06/2012
10	Hemorrhage 12/2022 - 03/2012
9	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 06/2010
8	Anemia 02/2024 - 01/2015
7	Hypoglycemia (Reactive Hypoglycemia) 01/2024 - 01/2011
7	Hypertension (High Blood Pressure) 05/2023 - 10/2006
7	Thrombosis (Thrombus) 05/2016 - 07/2010
6	Hyperkalemia 12/2023 - 12/2015
6	Neoplasms (Cancer) 01/2023 - 05/2010
6	Atrial Fibrillation 12/2022 - 02/2015
6	Diabetes Mellitus 01/2020 - 12/2012
6	Hypotension (Low Blood Pressure) 01/2020 - 06/2016
5	Rhabdomyolysis 05/2014 - 04/2009
4	Hypoxia (Hypoxemia) 02/2024 - 12/2021
4	Inflammation (Inflammations) 12/2023 - 10/2012
4	Weight Gain 06/2020 - 09/2015
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 10/2007
3	Ischemic Stroke 10/2022 - 06/2017
3	Edema (Dropsy) 12/2021 - 05/2014
3	Pancreatitis 12/2020 - 09/2018

Drug/Important Bio-Agent (IBA)

76	CanagliflozinIBA 01/2024 - 08/2013
64	CreatinineIBA 01/2024 - 04/2009
42	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2006
35	AlbuminsIBA 11/2023 - 10/2008
29	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2014
28	SodiumIBA 04/2024 - 08/2013
20	perindopril drug combination indapamideIBA 11/2019 - 08/2006
20	Gliclazide (Diamicron)IBA 11/2019 - 08/2006
18	Sodium-Glucose Transport ProteinsIBA 01/2024 - 03/2015
17	SymportersIBA 04/2024 - 08/2013
16	Hemoglobins (Hemoglobin)IBA 01/2024 - 03/2009
16	AtrasentanIBA 12/2023 - 05/2014
15	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2009
13	LinagliptinIBA 01/2024 - 11/2013
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 03/2008
12	HematinicsIBA 01/2024 - 07/2010
11	Perindopril FDA LinkGeneric 01/2019 - 01/2006
10	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2020
9	Angiotensin Receptor AntagonistsIBA 04/2024 - 09/2011
9	Indapamide FDA LinkGeneric 01/2019 - 01/2006
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023 - 09/2011
7	GSK1278863IBA 02/2024 - 12/2021
7	Erythropoietin FDA Link 02/2024 - 08/2013
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2008
7	CholesterolIBA 12/2022 - 03/2008
7	DiureticsIBA 10/2022 - 10/2006
7	Uric Acid (Urate)IBA 01/2022 - 01/2011
7	EnzymesIBA 01/2015 - 04/2009
7	LipidsIBA 05/2014 - 03/2008
6	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023 - 11/2020
6	Warfarin (Coumadin)FDA LinkGeneric 12/2022 - 11/2013
6	Endothelin Receptor AntagonistsIBA 11/2022 - 05/2014
6	PotassiumIBA 10/2022 - 12/2015
5	sparsentanIBA 04/2024 - 01/2023
5	Endothelins (Endothelin)IBA 04/2024 - 01/2017
5	Prolyl-Hydroxylase InhibitorsIBA 02/2024 - 12/2021
5	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2024 - 09/2015
5	AnticoagulantsIBA 12/2022 - 11/2013
5	Methylprednisolone FDA LinkGeneric 01/2022 - 01/2017
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2009
5	Phosphates (Orthophosphate)IBA 11/2020 - 07/2012
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 03/2009
4	Irbesartan FDA LinkGeneric 12/2023 - 01/2023
4	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 01/2020
4	HDL CholesterolIBA 01/2022 - 11/2011
4	Insulin (Novolin)FDA Link 01/2022 - 03/2015
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 10/2014
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 03/2012
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2024 - 01/2020
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024 - 09/2015
3	finerenoneIBA 12/2023 - 01/2023
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023 - 01/2018
3	Antihypertensive Agents (Antihypertensives)IBA 05/2023 - 12/2012
3	semaglutideIBA 01/2023 - 01/2021
3	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 02/2014
3	Darbepoetin alfa (Aranesp)FDA Link 01/2022 - 12/2021
3	SteroidsIBA 01/2021 - 06/2012
3	empagliflozinIBA 12/2020 - 01/2017

Therapy/Procedure

59	Therapeutics 04/2024 - 08/2006
11	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 06/2010
8	Kidney Transplantation 01/2024 - 05/2010
7	Glycemic Control 01/2023 - 03/2009
6	Renal Dialysis (Hemodialysis) 01/2024 - 01/2013
6	Transplantation 01/2023 - 05/2010
6	Surgical Amputation (Amputations) 10/2020 - 05/2016